UB, Partner Awarded $3 Million NIH Grant to Study Immune Cell Therapy for Tumors

The National Cancer Institute awarded Dr. Ruogang Zhao, professor of biomedical engineering at the University at Buffalo (UB), and a colleague a five-year, $3 million R01 research grant to study immune cell therapy for solid tumors.